b12 injections hydroxocobalamin at Olympia Hydroxocobalamin (B12) Injection, 2mg/mL |
Description
The selection of CD38 as a target molecule was a key step in the design of a mAb-mediated therapy for human multiple myeloma (MM)
Do not discontinue prescribed B12 treatment without medical advice, as this may be managing an important deficiency state
The incidence of adverse experiences described in the Table below are based on data from a short-term clinical trial in vitamin B12 deficient patients in hematologic remission receiving Nascobal (Cyanocobalamin, USP) Gel for Intranasal Administration (N=24) and intramuscular vitamin B12 (N=25)
Practitioner protocols address this with a separate full-length TB-4 bolus of 24 mg, two or three times weekly , alongside daily KLOW
